Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-18 Purchase |
2025-02-18 9:55 pm |
Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner |
30,000 | $0 | $0 | 4,618,780 (Direct) |
View |
| 2025-02-18 Purchase |
2025-02-18 9:54 pm |
Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn CEO and Exe. Chair of Board 10% Owner |
30,000 | $0 | $0 | 4,618,780 (Indirect) |
View |
| 2025-01-29 Purchase |
2025-02-04 7:41 pm |
Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner |
400,000 | $0 | $0 | 4,958,780 (Direct) |
View |
| 2025-01-29 Sale |
2025-02-04 7:41 pm |
Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner |
5,698,363 | $0 | $0 | 4,958,780 (Direct) |
View |
| 2025-01-29 Purchase |
2025-02-04 7:40 pm |
Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn CEO and Executive COB 10% Owner |
400,000 | $0 | $0 | 4,958,780 (Indirect) |
View |
| 2025-01-29 Sale |
2025-02-04 7:40 pm |
Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn CEO and Executive COB 10% Owner |
5,698,363 | $0 | $0 | 4,958,780 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-29 Other |
2025-02-04 7:41 pm |
N/A N/A |
Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner |
400,000 | $0 | 4,958,780 (Direct) |
View |
| 2025-01-29 Other |
2025-02-04 7:40 pm |
N/A N/A |
Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn CEO and Executive COB 10% Owner |
400,000 | $0 | 4,958,780 (Indirect) |
View |
| 2025-01-29 Other |
2025-02-03 7:27 pm |
N/A N/A |
Drugs Made In America Acquisition Corp. | DMAA | Shulgan Myron W. Director |
100,000 | $0 | 200,000 (Direct) |
View |
| 2025-01-29 Other |
2025-02-03 7:25 pm |
N/A N/A |
Drugs Made In America Acquisition Corp. | DMAA | Prasad Sridhar G. Director |
100,000 | $0 | 200,000 (Direct) |
View |
| 2025-01-29 Other |
2025-02-03 7:23 pm |
N/A N/A |
Drugs Made In America Acquisition Corp. | DMAA | Do Catherine Director |
100,000 | $0 | 200,000 (Direct) |
View |
| 2025-01-29 Other |
2025-02-03 7:21 pm |
N/A N/A |
Drugs Made In America Acquisition Corp. | DMAA | Worman Glenn C. CFO |
100,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2025-01-10 07:47 am |
N/A N/A |
Drugs Made In America Acquisition Corp. | DMAA | Drugs Made In America Acquisition LLC 10% Owner |
0 | $0 | 9,857,143 (Direct) |
View |
Ownership |
2025-01-10 07:45 am |
N/A N/A |
Drugs Made In America Acquisition Corp. | DMAA | Stockwell Lynn See Remarks 10% Owner |
0 | $0 | 9,857,143 (Indirect) |
View |